유경현 약력
■ Research Interest
1. Chromatin reorganization
2. Epigenetic reprogramming
3. Spatial genome
4. Oncogenic transcriptional control
5. multi-omics analysis
■ Education
학사 2004 숙명여자대학교 생명과학
석사 2006 숙명여자대학교 분자세포생물
박사 2009 숙명여자대학교 분자세포생물
■ Selected Publications
- Coordinated gene expression within sustained STAT3-associated chromatin conformations contributes to hepatocellular carcinoma progression. Jang SY, Yoon SM, Yang HJ, Choi NY, Han SH, Kim LK, Kim HP, Park JH, Lee DY, Yoo KH(*).Cancer Communications. 2025
- VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma. Han SH, Ko JY, Jung S, Oh S, Kim DY, Kang E, Kim MS, Chun KH, Yoo KH(*), Park JH. Exp Mol Med. 2024
- Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression. Oh S, Baek YH, Jung S, Yoon S, Kang B, Han SH, Park G, Ko JY, Han SY, Jeong JS, Cho JH, Roh YH, Lee SW, Choi GB, Lee YS, Kim W, Seong RH, Park JH, Lee YS, Yoo KH(*). Clin Mol Hepatol. 2024
- Hint from an Enzymatic Reaction: Superoxide Dismutase Models Efficiently Suppress Colorectal Cancer Cell Proliferation. Lim H, Oh C, Park MS, Park HB, Ahn C, Bae WK, Yoo KH(*), Hong S. J Am Chem Soc. 2023
- Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness. Oh C, Kim HR, Oh S, Ko JY, Kim Y, Kang K, Yang Y, Kim J, Park JH, Roe JS, Yoo KH(*). Cancers (Basel). 2021
- From genome sequencing to the discovery of potential biomarkers in liver disease.Oh S, Jo Y, Jung S, Yoon S, Yoo KH(*). BMB rep. 2020
- Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development. Ko JY, Oh S, Yoo KH(*),Mol Cells. 2017
- Facultative CTCF sites moderate mammary super-enhancer activity and regulate juxtaposed gene in non-mammary cells. Willi M, Yoo KH(*), Reinisch F, Kuhns TM, Lee HK, Wang C, Hennighausen L, Nature Communications. 2017
- Hierarchy within a mammary-specific and hormone-sensing super-enhancer. Shin HY, Willi M, Yoo KH(*), Zeng X, Wang C, Metser G, Hennighausen L, Nature Genetics, 2016
- Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes. Yoo KH(*), Oh S, Kang K, Hensel T, Robinson GW, Hennighausen L. Nucleic Acids Research. 2015
